檢索結果 - Neveu, David

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Tintin in CMAJ

    Tintin in CMAJ 由 Neveu, David

    出版 2005
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  2. 2
    1243. Semi-Quantitative Benefit-Risk Assessment for a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals 2 Years of Age and Older

    1243. Semi-Quantitative Benefit-Risk Assessment for a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals 2 Years of Age and Older 由 Neveu, David, Kürzinger, Marie-Laure, Chen, Aiying, Dhingra, Mandeep S

    出版 2020
    獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  3. 3
    2462. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Individuals 56 Years of Age and Older

    2462. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Individuals 56 Years of Age and Older 由 Jeanfreau, Robert, Esteves-Jaramillo, Alejandra, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S

    出版 2018
    獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  4. 4
    2719. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Adults 18–55 Years of Age

    2719. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Adults 18–55 Years of Age 由 Peterson, James, Hedrick, James, Pan, Judy, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S

    出版 2019
    獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  5. 5
    2723. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Adolescents 10–17 Years of Age

    2723. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Adolescents 10–17 Years of Age 由 Peterson, James, Hedrick, James, Pan, Judy, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S

    出版 2019
    獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  6. 6
    Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra(®)) in the Republic of Korea, 2014–2019

    Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra(®)) in the Republic of Korea, 2014–2019... 由 Kim, Hee Soo, Engel, Solene, Neveu, David, Thollot, Yael, Oster, Philipp, Yang, Kuhyun

    出版 2021
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  7. 7
    Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

    Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 y... 由 Piazza, Franco M., Virta, Miia, Paassilta, Marita, Ukkonen, Benita, Ahonen, Anitta, Esteves-Jaramillo, Alejandra, Forsten, Aino, Seppa, Ilkka, Ding, Jian, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S.

    出版 2021
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:

檢索工具: